Mikhail Gendel, MD
Adult Medicine · Gaithersburg, MDNPI 1235178344
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $878 and has fallen 73.3% since, to $235 in 2025. Among adult medicine clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 105 payments — averaging $31.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$404
- Orexo US, Inc.$284
- Gilead$264
- Novo Nordisk$253
- Abbott$230
- Amgen$193
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,28799%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 27 | $404 |
| Orexo US, Inc. | 15 | $284 |
| Gilead | 3 | $264 |
| Novo Nordisk | 3 | $253 |
| Abbott | 3 | $230 |
| Amgen | 6 | $193 |
| Alkermes, Inc. | 3 | $163 |
| Ironshore Pharmaceuticals Inc. | 2 | $158 |
| Pfizer | 2 | $138 |
| Ascensia Diabetes Care US Inc. | 1 | $123 |
| AstraZeneca | 1 | $122 |
| Optinose US, Inc. | 3 | $112 |
| Idorsia Pharmaceuticals US Inc | 1 | $105 |
| AbbVie | 6 | $97 |
| Lilly USA, LLC | 1 | $94 |
| Braeburn Inc. | 4 | $88 |
| Supernus Pharmaceuticals, Inc. | 4 | $85 |
| GSK | 3 | $78 |
| USWM, LLC | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $63 |
| Mylan Specialty L.p. | 1 | $25 |
| MDD US Operations, LLC | 1 | $24 |
| UCB, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| Seqirus USA Inc | 1 | $20 |
| Merck | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Shire North American Group Inc | 1 | $16 |
| Medtronic | 1 | $15 |
| Cranial Technologies, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Jornay PM 20mg capsules (Bottle of 100)$139
- VIVITROL$125
- Ozempic$122
- Yeztugo$122
- TEZSPIRE$122
- ELIQUIS$121
- FREESTYLE LIBRE 3$113
- RYBELSUS$107
- QUVIVIQ$105
- Repatha$105
How this compares
$3,319 in reported general payments places this provider in the 95th percentile of 34 adult medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 218 | $19,163 |
| Repatha SyringeEvolocumab | 19 | $11,854 |
| Nebivolol Hcl | 18 | $1,089 |
| Olmesartan Medoxomil | 26 | $905 |
| Atorvastatin Calcium | 81 | $715 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 15 | $513 |
| Famotidine | 21 | $399 |
| Metformin Hcl | 36 | $324 |
| Amlodipine Besylate | 57 | $300 |
| Zolpidem Tartrate | 32 | $273 |
| Hydroxyzine Hcl | 12 | $253 |
| Losartan Potassium | 23 | $252 |
| Rosuvastatin Calcium | 16 | $243 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 36 | $217 |
| Fluticasone Propionate | 26 | $192 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Gaithersburg
- Tibor FrekkoGaithersburg$320
- Derek McCoyBel Air$3K
- Joyce SunRockville$3K
- Achankunj ChackoTakoma Park$2K
- Holly HooverCumberland$1K
- Tracy TurnerAnnapolis$1K
- Vivien ToColumbia$1K
- Kamakshi BaigWhite Plains$810
- Elsie KamaraGermantown$788
- Asha ValiSilver Spring$692
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.